Metaphore Biotechnologies

Metaphore Biotechnologies

Biotechnology Research

Unlocking the therapeutic potential of biomimicry

About us

Metaphore Biotechnologies is harnessing the power of biomimicry and machine learning to unlock the transformative therapeutic potential of functional molecular mimics. The company’s MIMiC™ platform is a computationally driven bioplatform designing new therapeutics where function, specificity, and selectivity can be optimized. Metaphore is focused on making previously intractable drug targets accessible and unlocking breakthroughs that outperform today’s drugs for maximum patient impact. Metaphore was founded in 2021 in Flagship Labs, a unit of Flagship Pioneering.

Industry
Biotechnology Research
Company size
11-50 employees
Type
Privately Held

Employees at Metaphore Biotechnologies

Updates

Similar pages

Funding

Metaphore Biotechnologies 1 total round

Last Round

Undisclosed

US$ 50.0M

See more info on crunchbase